Executive pay

Vir Biotechnology (VIR) executive compensation

What Vir Biotechnology, Inc. paid its chief executive and named officers, year by year. Figures are automated and can be wrong; check the filing for the exact numbers.

  • 2026 proxy statement

    Marianne De Backer, M.Sc., Ph.D., MBA paid $7.8M (-15% on the year), pay ratio 24:1.

    Filed Apr 16, 2026